FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Vibramycin Hyclate (Doxycycline Hyclate) for Suspension
Status: Discontinuation
»Therapeutic Categories: Anti-Infective

Pfizer Pharmaceuticals (New 11/16/2021)

Company Contact Information:
800-533-4535

Presentation Posting Date Related Information
25 mg/5 mL oral suspension; 1 x 60 mL bottle (NDC 0069-0970-65) 11/16/2021 Discontinuation of the manufacture of the drug.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English